Abstract:Cyclodextrin glycosyltransferase (CGTase; EC 2.4.1.19) is an extracellular enzyme which converts starch into nonreducing, cyclic malto-oligosaccharides called cyclodextrins (CDs). It is a hydrolytic enzyme that carries out reversible intermolecular as well as intramolecular transglycosylation reaction toward cyclization, coupling, and disproportionation of malto-oligosaccharides. CD is a nonreducing closed-ring malto-oligosaccharide with glucose monomers linked with each other by α1 →4 glycosidic bonds. The most common form of CDs are consist with Six, seven, and eight glucose residues, i.e., α-, β-, γ-cyclodextrin, respectively. CGTase exhibits an axis of cyclization either with phenylalanine (Phe) or tyrosine (Tyr), essentially for the formation of CDs. The CGTase enzyme is efficient of transglycosylation and is specifically dependent on the centrally located Tyr residue for cyclization. Similarly, Phe and Arginine (Arg) are known for CD binding residues, whereas, lysine (Lys), and asparagine (Asp) are known for linear substrate binding residues of CGTase enzyme. The kinetics of coupling reaction exhibit the binding of both the donor (CD) and acceptor (monosaccharide) to the active binding cleft of the CGTase enzyme module before processing of CDs. Environmental 126conditions are regulatory aspects for growth of the microbial population and metabolic production. Enhanced CD production could be achieved through providing appropriate conditions. Induction of more thermostable CGTase enzymes are required to increase the CD production by ignoring the traditional problem of increase in temperature with inactivating the enzyme. Fermentation conditions such as the concentration of nutrients, temperature, and compositions of the carbon and nitrogen sources determine the optimum production of CGTase. Similarly, the CD-drug inclusion complex can be utilized for management of drug toxicity and regulated drug delivery. Cyclodextrin glycosyltransferase (CGTase) is an extracellular enzyme which converts starch into nonreducing, cyclic malto-oligosaccharides called cyclodextrins (CDs). In modern days, CDs perform as a recognized guest molecule in the area of molecular complexation. CDs are primarily cyclic, cage-like glucose residues produced from enzymatic hydrolysis of starch with help of the enzyme CGTase. An appropriate guest molecule substitutes the water from the CD cavity, leading to the formation of the CD-inclusion complex. The solubility of inclusion complex and CDs are inversely proportional to each other. Inclusion complex with guest molecule of low water solubility usually results with decrease in solubility of CD, where solubility of inclusion complex is generally less than that of the CD, and greater than the guest molecule. Encapsulation of drug molecules within CD as guest molecules has become an area of new interest for efficient drug delivery function.

Kinetics guided engineering of cyclodextrin glycosyltransferase with enhanced intermolecular transglycosylation activity

Engineering of Cyclodextrin Glycosyltransferase through a Size/Polarity Guided Triple-Code Strategy with Enhanced alpha-Glycosyl Hesperidin Synthesis Ability

Rational Design of Cyclodextrin Glycosyltransferase with Improved Hesperidin Glycosylation Activity

Engineering of Cyclodextrin Glycosyltransferase through a Size/Polarity Guided Triple-Code Strategy with Enhanced α-Glycosyl Hesperidin Synthesis Ability

Improved Activity of Β-Cyclodextrin Glycosyltransferase from Bacillus Sp. N-227 Via Mutagenesis of the Conserved Residues.

Optimization of the fermentation conditions for the mutant strain of β-cyclodextrin glycosyltransferase H167C to produce cyclodextrins

Surface engineering of cyclodextrin glycosyltransferase reveals structural compactness and rigidity responsible for enhanced organic solvents resistance

[Breeding, Optimized Fermentation and Enzymatic Properties of a Bacillus Licheniformis Mutant Producing Cyclomaltodextrin Glucanotransferase].

Engineering of cyclodextrin glycosyltransferase from Paenibacillus macerans for enhanced product specificity of long-chain glycosylated sophoricosides

Fusion of a family 20 carbohydrate-binding module (CBM20) with cyclodextrin glycosyltransferase of Geobacillus sp. CHB1 improves catalytic efficiency

Molecular dynamic analysis of mutant Y195I α-cyclodextrin glycosyltransferase with switched product specificity from α-cyclodextrin to γ-cyclodextrin

Cyclodextrin Glycosyltransferase Variants Experience Different Modes of Product Inhibition

Site-saturation Mutagenesis of Proline 176 in Cyclodextrin Glucosyltransferase from Bacillus Sp. Y112 Effects Product Specificity and Enzymatic Properties

Maltose binding site 2 mutations affect product inhibition of Bacillus circulans STB01 cyclodextrin glycosyltransferase

Enhancing the α-Cyclodextrin Specificity of Cyclodextrin Glycosyltransferase from Paenibacillus macerans by Mutagenesis Masking Subsite -7

Molecular mechanism of acceptor selection in cyclodextrin glycosyltransferases catalyzed ginsenoside transglycosylation

Strategies for modulating transglycosylation activity, substrate specificity, and product polymerization degree of engineered transglycosylases

Thermostable Cyclodextrin Glycosyltransferase (CGTase): Recent Advances in Pharmaceutical Application of Cyclodextrins and Its Enzymatic Production

Advance in cyclodextrin glycosyltransferase

Mutations at Subsite −3 in Cyclodextrin Glycosyltransferase from Paenibacillus Macerans Enhancing Α-Cyclodextrin Specificity

Mutations at calcium binding site III in cyclodextrin glycosyltransferase improve β-cyclodextrin specificity